Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • 2025
  • July
  • Page 14
decoding-fls2-unveils-broad-pathogen-detection-principles
Posted inBiotechnology

Decoding FLS2 Unveils Broad Pathogen Detection Principles

July 28, 2025
In the intricate battlefield of plant-pathogen interactions, the ability of plants to perceive and respond to microbial threats is paramount.…
Read More
adaptimmune-sells-4-cell-therapies-to-pharma-for-$55m,-plans-layoffs
Posted inBiotechnology

Adaptimmune sells 4 cell therapies to pharma for $55M, plans layoffs

July 28, 2025
After months of searching for strategic options, Adaptimmune is offloading its cell therapies to a global pharma, which plans to…
Read More
maplight-raises-$373m-to-plot-phase-2-journey-for-would-be-rival-to-bms’-cobenfy
Posted inBiotechnology

MapLight raises $373M to plot phase 2 journey for would-be rival to BMS’ Cobenfy

July 28, 2025
MapLight Therapeutics has raised a $372.5 million series D round, clearing the biotech to chart a course through phase 2 for…
Read More
boehringer-eyes-$1b-deal-to-use-re-vana’s-drug-delivery-tech-on-ophthalmic-pipeline
Posted inBiotechnology

Boehringer eyes $1B deal to use Re-Vana’s drug delivery tech on ophthalmic pipeline

July 28, 2025
Boehringer Ingelheim is continuing to explore its newfound enthusiasm for eye health, penning a $1 billion biobucks pact with Re-Vana…
Read More
celcuity’s-breast-cancer-combo-hits-primary-endpoints,-teeing-up-fda-filing
Posted inBiotechnology

Celcuity’s breast cancer combo hits primary endpoints, teeing up FDA filing

July 28, 2025
A phase 3 trial of Celcuity’s breast cancer combination has hit its primary endpoints, blasting past the biotech’s bar for…
Read More
atai’s-schizophrenia-drug-fails-to-improve-cognition-in-phase-2-study
Posted inBiotechnology

Atai’s schizophrenia drug fails to improve cognition in phase 2 study

July 28, 2025
Atai Life Sciences’ schizophrenia drug has failed to improve cognition in a phase 2 study, leading the biotech to reaffirm…
Read More
gsk-strengthens-copd-offering-via-$12b-biobucks,-12-program-deal-with-china’s-hengrui-pharma
Posted inBiotechnology

GSK strengthens COPD offering via $12B biobucks, 12-program deal with China’s Hengrui Pharma

July 28, 2025
Having recently scored approval for Nucala in chronic obstructive pulmonary disease (COPD), GSK has now signed a major $12 billion…
Read More
mass-administration-of-ivermectin-slows-malaria-transmission-in-kenya
Posted inGenetics

Mass Administration of Ivermectin Slows Malaria Transmission in Kenya

July 28, 2025
Despite the headlines a few years ago, ivermectin is not an effective treatment for COVID-19. However, the broad-spectrum antiparasitic drug…
Read More
mitophagy-mechanism-unlocks-therapy-path-for-parkinson’s-disease
Posted inGenetics

Mitophagy Mechanism Unlocks Therapy Path for Parkinson’s Disease

July 28, 2025
Autophagy is a natural, conserved process where cells degrade and recycle their own components, including damaged proteins and organelles. This…
Read More
advanced-pressure-velocity-patch-enhances-flight-detection
Posted inBiotechnology

Advanced Pressure-Velocity Patch Enhances Flight Detection

July 27, 2025
In the rapidly evolving field of aerospace technology, the development of advanced sensing mechanisms is vital for improving the safety,…
Read More

Posts pagination

Previous page 1 … 12 13 14 15 16 … 61 Next page

Privacy Policy    Terms

Scroll to Top